Bioscript

BYT-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about BYT-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 17, 2007
Doesn't follow it very closely. Thinks, that maybe it's failing.
Show full opinionHide full opinion
Bioscript (BYT-T)
August 17, 2007
Doesn't follow it very closely. Thinks, that maybe it's failing.
DON'T BUY
DON'T BUY
December 8, 2006
Market has indicated this company is in trouble. Negative earnings and he doesn’t see any prospect for that to turn around.
Show full opinionHide full opinion
Bioscript (BYT-T)
December 8, 2006
Market has indicated this company is in trouble. Negative earnings and he doesn’t see any prospect for that to turn around.
DON'T BUY
DON'T BUY
September 15, 2006
Ranks 631 in the database which is in the bottom 15%. Expected to lose $0.03 in 2007 compared to $0.07 in 2006. Earnings growth is modest at 5%.
Show full opinionHide full opinion
Bioscript (BYT-T)
September 15, 2006
Ranks 631 in the database which is in the bottom 15%. Expected to lose $0.03 in 2007 compared to $0.07 in 2006. Earnings growth is modest at 5%.
DON'T BUY
DON'T BUY
September 7, 2006
Not successful in finding good investment opportunities in this sector. Wants sustainable competitive advantage, good valuations and good technicals. This one’s valuations have dropped enough that he will be taking a look at it.
Show full opinionHide full opinion
Bioscript (BYT-T)
September 7, 2006
Not successful in finding good investment opportunities in this sector. Wants sustainable competitive advantage, good valuations and good technicals. This one’s valuations have dropped enough that he will be taking a look at it.
DON'T BUY
DON'T BUY
August 18, 2006
Involved in the security sector. Performed much better some time ago. Some of the small caps are having a bit of trouble. They need to show more contracts. Earnings tend to be a little on the spotty side.
Show full opinionHide full opinion
Bioscript (BYT-T)
August 18, 2006
Involved in the security sector. Performed much better some time ago. Some of the small caps are having a bit of trouble. They need to show more contracts. Earnings tend to be a little on the spotty side.
DON'T BUY
DON'T BUY
July 25, 2006
Ranks 594, bottom 10/15% of the database. Earnings estimates have been shaved by 6%. Expected to lose$.07 in 06 and $.09 in 07.
Show full opinionHide full opinion
Bioscript (BYT-T)
July 25, 2006
Ranks 594, bottom 10/15% of the database. Earnings estimates have been shaved by 6%. Expected to lose$.07 in 06 and $.09 in 07.
DON'T BUY
DON'T BUY
March 13, 2006
This company is involved in high security. It is in the bottom 1-2% of the database. He has doubts. It is interesting technology but there are better places to be.
Show full opinionHide full opinion
Bioscript (BYT-T)
March 13, 2006
This company is involved in high security. It is in the bottom 1-2% of the database. He has doubts. It is interesting technology but there are better places to be.
DON'T BUY
DON'T BUY
January 12, 2006
In the bottom 10% of his database. Earnings have been shaved by 5% in the last 90 days.Year over year earnings growth is down 22%. They are forecasted to lose $.09 in '05.
Show full opinionHide full opinion
Bioscript (BYT-T)
January 12, 2006
In the bottom 10% of his database. Earnings have been shaved by 5% in the last 90 days.Year over year earnings growth is down 22%. They are forecasted to lose $.09 in '05.
DON'T BUY
DON'T BUY
October 27, 2005
Have had some pretty good sales numbers. Analysts have chopped estimates by 41%. Ranks 619 out of 700 in the database.
Show full opinionHide full opinion
Bioscript (BYT-T)
October 27, 2005
Have had some pretty good sales numbers. Analysts have chopped estimates by 41%. Ranks 619 out of 700 in the database.
DON'T BUY
DON'T BUY
December 9, 2004
Expected to lose $0.05 in Dec'04 and $0.03 in '05. Trades at 160 X PE. Too expensive.
Show full opinionHide full opinion
Bioscript (BYT-T)
December 9, 2004
Expected to lose $0.05 in Dec'04 and $0.03 in '05. Trades at 160 X PE. Too expensive.
BUY WEAKNESS
BUY WEAKNESS
November 4, 2004
It bounces up and down based on contract announcements. Treat as a trading vehicle. A pretty good company.
Show full opinionHide full opinion
Bioscript (BYT-T)
November 4, 2004
It bounces up and down based on contract announcements. Treat as a trading vehicle. A pretty good company.
WEAK BUY
WEAK BUY
July 8, 2004
Likes the technology, management and balance sheet. Have some good customers and getting good penetration. A little early to get real excited as to where it can go.
Show full opinionHide full opinion
Bioscript (BYT-T)
July 8, 2004
Likes the technology, management and balance sheet. Have some good customers and getting good penetration. A little early to get real excited as to where it can go.
BUY WEAKNESS
BUY WEAKNESS
May 17, 2004
Likes their technology. Good management stability. Have key brand name clients that are starting to sign up. Could drop another 20/30%.
Show full opinionHide full opinion
Bioscript (BYT-T)
May 17, 2004
Likes their technology. Good management stability. Have key brand name clients that are starting to sign up. Could drop another 20/30%.
BUY
BUY
April 8, 2004
Likes their technology. Have very high profile customers like Bloomberg and the Bank of China. Had a tough year last year. Could do well going forward.
Show full opinionHide full opinion
Bioscript (BYT-T)
April 8, 2004
Likes their technology. Have very high profile customers like Bloomberg and the Bank of China. Had a tough year last year. Could do well going forward.
BUY
BUY
March 2, 2004
Their deal with the Bank of China is significant. Have also signed Bloomberg Partnership as a partner. Huge endorsement.
Show full opinionHide full opinion
Bioscript (BYT-T)
March 2, 2004
Their deal with the Bank of China is significant. Have also signed Bloomberg Partnership as a partner. Huge endorsement.
WAIT
WAIT
February 12, 2004
In the borderline of the top quarter of the database. Earnings will rise from a loss of $ .09 to a loss of $ .01 in 2004. Sales are up. The trend is upwards, but still not on the positive side.
Show full opinionHide full opinion
Bioscript (BYT-T)
February 12, 2004
In the borderline of the top quarter of the database. Earnings will rise from a loss of $ .09 to a loss of $ .01 in 2004. Sales are up. The trend is upwards, but still not on the positive side.
WEAK BUY
WEAK BUY
September 9, 2003
Pretty competitive field, but security is a hot sector now. Pretty decent technology. Would like to see more revenue and re-curring revenue and additional contracts.
Show full opinionHide full opinion
Bioscript (BYT-T)
September 9, 2003
Pretty competitive field, but security is a hot sector now. Pretty decent technology. Would like to see more revenue and re-curring revenue and additional contracts.
BUY
BUY
December 31, 2001
Has a new contract.
Show full opinionHide full opinion
Bioscript (BYT-T)
December 31, 2001
Has a new contract.
Showing 1 to 18 of 18 entries
  • «
  • 1
  • »

Bioscript(BYT-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Bioscript is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Bioscript(BYT-T) Frequently Asked Questions

What is Bioscript stock symbol?

Bioscript is a OTC stock, trading under the symbol BYT-T on the (). It is usually referred to as or BYT-T

Is Bioscript a buy or a sell?

In the last year, there was no coverage of Bioscript published on Stockchase.

Is Bioscript a good investment or a top pick?

Bioscript was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Bioscript.

Why is Bioscript stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Bioscript worth watching?

In the last year 0 stock analyst on Stockchase covered Bioscript. The stock is worth watching.

What is Bioscript stock price?

On , Bioscript (BYT-T) stock closed at a price of $.